- Home
- MANH vs PEN Comparison
MANH vs PEN Comparison
Compare MANH & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MANH | PEN |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 12.8B |
| IPO Year | 1998 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MANH | PEN |
|---|---|---|
| Price | $241.34 | $325.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 17 |
| Target Price | $230.20 | ★ $362.54 |
| AVG Volume (30 Days) | ★ 494.5K | 304.6K |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.56 | ★ 1155.56 |
| EPS | 1.67 | ★ 1.70 |
| Revenue | $131,300,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $7.77 | $13.46 |
| Revenue Next Year | $8.55 | $13.01 |
| P/E Ratio | ★ $141.34 | $190.56 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $119.06 | $221.26 |
| 52 Week High | $236.62 | $362.41 |
Technical Indicators
Market Signals| Indicator | MANH | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 65.87 |
| Support Level | $125.51 | $315.42 |
| Resistance Level | N/A | $329.14 |
| Average True Range (ATR) | 6.79 | 1.94 |
| MACD | 2.97 | 0.81 |
| Stochastic Oscillator | 94.38 | 96.08 |
Price Performance
Historical ComparisonAbout MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers worldwide.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.